Lift Off! Mustang Bio (MBIO) $9.31 Jumps 4-Fold.

‘Bubble Boy’ Biotech Soars 250 Percent After Cure Announcement (Bloomberg). (Bloomberg) -- Shares of the tiny biotechnology company Mustang Bio Inc. more than tripled Thursday,...
biotech stock review

Mustang Bio (MBIO)$4.12, Reports 2018 Results.

Mustang Bio Reports Full-Year 2018 Financial Results And Recent Corporate Highlights GlobeNewswire - Mon Mar 18, 6:29AM CDT Mustang Bio, Inc. ("Mustang") (NASDAQ:MBIO), a clinical-stage biopharmaceutical company focused...
Immuron, Superbug Stock Review

Adding Immuron (IMRN) $2.57 to Superbug Watchlist.

CLICK FOR LIVE QUOTE SUPER BUG STOCK REVIEW Prevent Montezuma's Revenge BEFORE it starts! Immuron's direct to consumer product Travelan® is a huge hit with international...
biotech stock review, fluticare

Innovus (INNV): Twenty-Eight Drugs in Five Years. (San Diego Reader)

(Originally published 4/25/2018) “I am very steady. I like to work slowly, but surely, to get to my goal.” Thus speaks Bassam Damaj, president and...
biotech stock review, innovus

Adding Innovus Pharma (INNV) $2.50 to Watch List.

Fast Growing eCommerce and Direct to Consumer Pharma Company Announces 1st Foray into CBD and 2nd Major Off-Patent Blockbuster Drug to its lineup. We're adding...
biotech stock review, zestra

Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for Female Sexual Arousal!

Dubai based Lavasta is a pharmaceutical marketing company that offers niched unique medications based on the latest scientific innovations that defy current therapeutic conventions....
Regoxidine, biotech stock review

Rogaine® Competitor Regoxidine™ Expected to Launch Second Half, 2019.

Innovus Pharma (INNV) Announces a Second Partnered United States OTC ANDA for Minoxidil 5% Foam for Men and Women. Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or...

Hercules BDC (HTGC) $13, to Present at FB Riley.

Hercules Capital to Discuss 2019 Growth Opportunities at the B. Riley FBR Institutional Investor Conference PALO ALTO, Calif.--(BUSINESS WIRE)-- Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the...

Innovus (INNV) in Silicon Review Interview.

POISED FOR INNOVATION. The Silicon Review is the world’s most trusted online and print community for business & technology professionals. Our community members include thought-provoking...

Latest article

Latest Research Report: $20 Price Target from Greenridge Global.

Here are four research reports below to peruse, all with price targets $20.00 or more... While we don't issue price targets, it's comforting to see...

Three More Companies Suspended by SEC!

Millions of Investor's Dollars are Being Trapped. These three companies had a combined market cap of $563 million at the time they were halted, whose...

AI Data Center Short – Jim Chanos

“If the economic life on these things is three years ... the whole economics of a lot of these deals kind of falls...